Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Alnylam Pharmaceuticals, Inc. (ALNY) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home ...

Shares in Alnylam were up almost 56% at one point yesterday, while rival Ionis saw its shares slump 9%. Shares in The Medicines Company were also up 5.7% thanks to an RNAi licensing deal with Alnylam.

The King's Birthday Honours list for 2025 has been published with more than 1,200 people from across the UK being recognised for their achievements. Twice a year, special honours are granted to ...

With the first amyloid-targeting drug now approved for Alzheimer’s disease, Alnylam has presented preliminary clinical results with a new candidate that could potentially be dosed as ...

The King's Birthday Honours mark the extraordinary contributions and service of people across the UK. More than 1,000 people were recognised by the King this week. Along with the New Year Honours ...

Chief Executive Officer, Raspberry Pi Foundation. For services to Engineering and Technology ... (Birmingham, West Midlands) Professor Pankaj Sharma. Director, Institute of Cardiovascular Research, ...